These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1761079)

  • 1. Dose-proportionality of eltoprazine. Pharmacokinetics of single oral doses in healthy subjects.
    de Vries MH; de Koning P; Floot HL; Grahnén A; Eckernäs SA; Raghoebar M; Dahlström B; Ekman L
    Eur J Clin Pharmacol; 1991; 41(5):485-8. PubMed ID: 1761079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of eltoprazine in healthy male subjects after single dose oral and intravenous administration.
    Raghoebar M; Mak M; Cournot A; Pistorius MC; Van Harten J; Roseboom H
    Br J Clin Pharmacol; 1990 Dec; 30(6):879-83. PubMed ID: 2288834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of eltoprazine in healthy subjects.
    van Harten J; Mathlener IS; Raghoebar M
    Drug Metabol Drug Interact; 1990; 8(1-2):149-58. PubMed ID: 2091888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of eltoprazine in the dog.
    Lammers R; van Harten J
    Drug Metabol Drug Interact; 1990; 8(1-2):141-8. PubMed ID: 2091887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans.
    Nakashima M; Uematsu T; Kosuge K; Kusajima H; Ooie T; Masuda Y; Ishida R; Uchida H
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2635-40. PubMed ID: 8592993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, tolerability and pharmacokinetics of the new long-acting quinolone DW-116 after single and multiple dosing in healthy subjects.
    Meyerhoff C; Dilger C; Yoon SJ; Chung YH; Lee DK; Lee CW; Ryu JM; Choi MS; Pabst G; Reh C
    J Antimicrob Chemother; 1998 Sep; 42(3):349-61. PubMed ID: 9786475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study.
    Svenningsson P; Rosenblad C; Af Edholm Arvidsson K; Wictorin K; Keywood C; Shankar B; Lowe DA; Björklund A; Widner H
    Brain; 2015 Apr; 138(Pt 4):963-73. PubMed ID: 25669730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of food on the absorption and pharmacokinetics of rivaroxaban.
    Stampfuss J; Kubitza D; Becka M; Mueck W
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
    Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the pharmacokinetics, food effect, pharmacodynamics, and tolerability of DA-1229, a dipeptidyl peptidase IV inhibitor, in healthy volunteers: first-in-human study.
    Kim TE; Lim KS; Park MK; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2012 Sep; 34(9):1986-98. PubMed ID: 22943970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of procaterol: dose proportionality after administration of single oral doses.
    Eldon MA; Blake DS; Coon MJ; Nordblom GD; Sedman AJ; Colburn WA
    Biopharm Drug Dispos; 1992 Dec; 13(9):663-9. PubMed ID: 1467453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic properties of mirabegron, a β3-adrenoceptor agonist: results from two phase I, randomized, multiple-dose studies in healthy young and elderly men and women.
    Krauwinkel W; van Dijk J; Schaddelee M; Eltink C; Meijer J; Strabach G; van Marle S; Kerbusch V; van Gelderen M
    Clin Ther; 2012 Oct; 34(10):2144-60. PubMed ID: 23063375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, tolerability, and pharmacokinetics of a single ascending dose of baicalein chewable tablets in healthy subjects.
    Li M; Shi A; Pang H; Xue W; Li Y; Cao G; Yan B; Dong F; Li K; Xiao W; He G; Du G; Hu X
    J Ethnopharmacol; 2014 Oct; 156():210-5. PubMed ID: 25219601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses.
    Moore KH; Hussey EK; Shaw S; Fuseau E; Duquesnoy C; Pakes GE
    Cephalalgia; 1997 Jun; 17(4):541-50. PubMed ID: 9209776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and pharmacokinetics of mifentidine after increasing oral doses in healthy subjects.
    Imbimbo BP; Seiberling M; Peuckert U; Hoexter G; Maier-Lenz H; Vidi A; Daniotti S
    Eur J Clin Pharmacol; 1988; 35(6):673-6. PubMed ID: 2906876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, tolerability, pharmacokinetics, and pharmacodynamics of fimasartan following single and repeated oral administration in the fasted and fed states in healthy subjects.
    Chi YH; Lee H; Paik SH; Lee JH; Yoo BW; Kim JH; Tan HK; Kim SL
    Am J Cardiovasc Drugs; 2011 Oct; 11(5):335-46. PubMed ID: 21910510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady state pharmacokinetics and dose-proportionality of phenylpropanolamine in healthy subjects.
    Scherzinger SS; Dowse R; Kanfer I
    J Clin Pharmacol; 1990 Apr; 30(4):372-7. PubMed ID: 2341583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single- and multiple-dose pharmacokinetics of nefiracetam, a new nootropic agent, in healthy volunteers.
    Fujimaki Y; Sudo K; Hakusui H; Tachizawa H; Murasaki M
    J Pharm Pharmacol; 1992 Sep; 44(9):750-4. PubMed ID: 1360528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic evaluation of eltoprazine.
    Wigal SB; Duong S
    Expert Opin Drug Metab Toxicol; 2011 Jun; 7(6):775-81. PubMed ID: 21548716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.